Pınar, İbrahim Ethem, and Vildan Ozkocaman. “Efficacy and Safety Outcomes of Single-Agent Ibrutinib Therapy in Chronic Lymphocytic Leukemia and Relapsed Refractory Mantle-Cell Lymphoma”. The European Research Journal, vol. 9, no. 6, Nov. 2023, pp. 1483-92, https://doi.org/10.18621/eurj.1359362.